Jorge Sabbaga
Overview
Explore the profile of Jorge Sabbaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva M, Sabbaga J, Najman H, Nascimento C, Cotta-Pereira R, Nicoluzzi J, et al.
Arq Bras Cir Dig
. 2025 Feb;
37:e1869.
PMID: 39936820
Colorectal cancer (CRC) is a common disease, with incidence in Brazil of 45,630 new cases per 100,000 inhabitants between 2023-2025. Risk factors for CRC can be evaluated between environmental and...
2.
Braghiroli M, Sobral Filho D, Fagundes J, Mendoza E, Neffa M, Campos K, et al.
Cancer Treat Res Commun
. 2025 Jan;
42:100867.
PMID: 39799855
Purpose: There is evidence that adding cetuximab can overcome resistance to irinotecan, but a similar analysis with Panitumumab isn't readily available. This study evaluated the activity of each anti-EGFR plus...
3.
Protasio B, de Castria T, Natalino R, Mangone F, Saragiotto D, Sabbaga J, et al.
Clin Colorectal Cancer
. 2023 Dec;
23(1):73-84.
PMID: 38151358
Background: Primary tumor sidedness (PTS) is an independent prognostic factor in patients with metastatic colorectal cancer (CRC), with a worse prognosis for right-sided tumors. There are limited data on the...
4.
Habr-Gama A, Sao Juliao G, Ortega C, Vailati B, Araujo S, Jorge T, et al.
BMC Cancer
. 2023 Jun;
23(1):546.
PMID: 37316784
Background: Neoadjuvant chemoradiation(nCRT) has been considered the preferred initial treatment strategy for distal rectal cancer. Advantages of this approach include improved local control after radical surgery but also the opportunity...
5.
Capareli F, Costa F, Tuszynski J, Sousa M, Setogute Y, Lima P, et al.
Cancer Med
. 2023 May;
12(11):12402-12412.
PMID: 37184216
Background: Patients with advanced hepatocellular carcinoma (HCC) and poor liver function lack effective systemic therapies. Low-energy electromagnetic fields (EMFs) can influence cell biological processes via non-thermal effects and may represent...
6.
Xavier C, Link R, Abreu L, Bettoni F, Marson F, Galante P, et al.
Oncologist
. 2023 May;
28(7):624-627.
PMID: 37159554
Objective: Li-Fraumeni syndrome (LFS) is a pan-cancer predisposition syndrome caused by germline pathogenic variants in the gene TP53. The interpretation of TP53 variants in clinical scenarios outside the classic LFS...
7.
Barreiro R, Sabbaga J, Rossi B, Achatz M, Bettoni F, Camargo A, et al.
J Pathol
. 2021 Nov;
256(2):214-222.
PMID: 34816434
MUTYH encodes a glycosylase involved in the base excision repair of DNA. Biallelic pathogenic germline variants in MUTYH cause an autosomal recessive condition known as MUTYH-associated adenomatous polyposis and consequently...
8.
Moniz C, Riechelmann R, Oliveira S, Bariani G, Rivelli T, Ortega C, et al.
J Cancer
. 2021 Nov;
12(23):7018-7025.
PMID: 34729104
Although Chemoradiation (CRT) is the curative treatment for SCCAC, many patients present primary resistance. Since it is a rare tumor, response predictors remain unknown. We performed a prospective cohort study...
9.
Bonadio R, Freitas G, Batista D, Moreira O, Dias C, Castria T, et al.
Clin Colorectal Cancer
. 2021 May;
20(3):e195-e200.
PMID: 33966961
Background: Brain metastases (BMs) from colorectal cancer (CRC) are unusual; however, an increase in incidence has been reported. The evidence available on the subject is scarce, and a better understanding...
10.
Marta G, da Fonseca L, Braghiroli M, Moura F, Hoff P, Sabbaga J
Clinics (Sao Paulo)
. 2021 Jan;
76:e2498.
PMID: 33503195
Objectives: To evaluate the efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC). Methods: We analyzed data from a cohort of patients with advanced HCC treated...